Target Price | $5.00 |
Price | $0.98 |
Potential |
409.79%
register free of charge
|
Number of Estimates | 4 |
4 Analysts have issued a price target Unity Biotechnology, Inc. 2026 .
The average Unity Biotechnology, Inc. target price is $5.00.
This is
409.79%
register free of charge
$6.00
511.75%
register free of charge
$4.00
307.83%
register free of charge
|
|
A rating was issued by 4 analysts: 4 Analysts recommend Unity Biotechnology, Inc. to buy, 0 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Unity Biotechnology, Inc. stock has an average upside potential 2026 of
409.79%
register free of charge
|
Dec '24 |
2025 Estimates |
|
---|---|---|
EV/Sales | 45.06 |
Unity Biotechnology, Inc....
Analyst | Rating | Action | Date |
---|---|---|---|
Chardan Capital |
Locked
➜
Locked
|
Locked | Apr 23 2025 |
HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Apr 23 2025 |
Chardan Capital |
Locked
➜
Locked
|
Locked | Mar 25 2025 |
HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Mar 25 2025 |
HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Mar 24 2025 |
Chardan Capital |
Locked
➜
Locked
|
Locked | Mar 10 2025 |
HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Mar 10 2025 |
Analyst Rating | Date |
---|---|
Locked
Chardan Capital:
Locked
➜
Locked
|
Apr 23 2025 |
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Apr 23 2025 |
Locked
Chardan Capital:
Locked
➜
Locked
|
Mar 25 2025 |
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Mar 25 2025 |
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Mar 24 2025 |
Locked
Chardan Capital:
Locked
➜
Locked
|
Mar 10 2025 |
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Mar 10 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.